Mirabilis Medica brings in $5 million
Uterine fibroid-treating device developer Mirabilis Medica raised $5 million in a new round of debt financing, according to an SEC filing posted today. The company’s Mirabilis system is designed to...
View ArticleSmith & Nephew closes $350m Truclear sale to Medtronic, launches $300m buyback
Smith & Nephew (NYSE:SNN) said today that it closed the $350 million sale of its gynecology business, including the Truclear hysteroscopy system, to Medtronic (NYSE:MDT). The London-based...
View ArticleANVISA officially extends deadline for IVD and cadastro technical dossier...
By Stewart Eisenhart, Emergo Group Brazil’s medical device regulator ANVISA has announced official extensions for deadlines to file technical dossiers for low-risk cadastro medical devices as well as...
View ArticleSunshine Heart pays $5m for Baxter’s Aquadex
Sunshine Heart (NSDQ:SSH) said today that it agreed to pay about $5 million for the Aquadex fluid filtration device Baxter (NYSE:BAX) acquired when it bought Gambro in 2013. The Aquadex device is...
View ArticleMedtronic wins CE Mark for SureTune2 DBS software
Medtronic (NYSE:MDT) said today that it won CE Mark approval in the European Union for the SureTune2 software used with its deep-brain stimulation devices. The software is designed to allow physicians...
View ArticleAlere ticks up after reporting delayed 2015 results
Shares in Alere (NYSE:ALR) ticked up today after the diagnostics giant reported its long-delayed financial results ahead of its $6 billion union with Abbott (NYSE:ABT). Alere, which last month cut its...
View ArticleFreudenberg Medical lifts Kley to CEO
Freudenberg Medical said today it promoted Dr. Max Kley to chief executive officer, effective August 1. Get the rest of the story at our sister site, Medical Design & Outsourcing The post...
View ArticleSt. Jude Medical reverses course on covering top execs’ tax tabs
St. Jude Medical (NYSE:STJ) reversed course on a pledge it made earlier this year not to cover some of tax tab its senior executives could incur after its $25 billion merger with Abbott (NYSE:ABT). St....
View ArticleSynthes settles; doc, hospital cleared in Norian XR bone cement suit
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes last week reportedly settled with plaintiffs shortly before a Washington state court jury cleared Dr. Jens Chapman and the University of...
View ArticleUniversity of California pays $9m to settle Medtronic InFuse suits
The regents governing the University of California reportedly agreed to pony up $8.5 million to settle a pair of lawsuits brought against a former UCLA spine surgeon who used MDT’s controversial InFuse...
View ArticleCyberHeart inks development deal with Japan’s National Cancer Center
Cardiovascular radiosurgery developer CyberHeart said today it inked its 1st development deal to install its CyberHeart system in Tokyo’s National Cancer Center, making it the 1st non-invasive cardiac...
View Article3 Keys to Maximize Your Investment in Sales Asset Management
By Melyssa Plunkett-Gomez, Sales Executive, Allego In recent years, the Sales Asset Management (SAM) market – Sales Playbooks, Sales Content Management – has exploded. With relatively new entrants like...
View ArticleBayer can’t dodge Essure lawsuits in California
Bayer (ETR:BAYN) can’t dodge a clutch of lawsuits filed by patients alleging their injuries were caused by its Essure female sterilization device, a California state judge ruled last week. Three...
View ArticleMassDevice.com +5 | The top 5 medtech stories for August 8, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleReShape Medical taps Sirtex prez Mangano for CEO
ReShape Medical taps Sirtex prez Mangano for CEO ReShape Medical said today it tapped former Sirtex president Michael Mangano as its new prez and chief executive officer. During his time at Sirtex,...
View ArticleInSeal Medical wins CE Mark for vascular closure device
InSeal Medical said today it won CE Mark approval in the European Union for its InClosure vascular closure device designed to close large bore arterial punctures. The device is implanted percutaneously...
View ArticleCheck-Cap raises $6m
Check-Cap (NSDQ:CHEK) said today it raised $5.9 million through a direct placement with a single health-care focused institutional investor. The money comes through the sale of 643,614 ordinary shares...
View ArticleElectroCore raises $1.5m
ElectroCore raised $1.5 million in a new round of debt financing, according to an SEC filing posted today. ElectroCore is developing a range of non-invasive vagus nerve stimulation for the treatment of...
View ArticleDentsply Sirona shares slip despite beating expectations in Q2
Dentsply Sirona (NSDQ:XRAY) reported 2nd quarter earnings that topped The Street, but still saw shares tumble in response. The York, Penn.-based company reported profits of $105 million, or 44¢ per...
View ArticleThe long hike: A pediatric vision scanner’s journey to market
As a pediatric ophthalmologist, I do my best to assure that every young patient I examine will have a lifetime of perfect sight. The condition that I battle most commonly is amblyopia, or “lazy eye,”...
View Article